Tumor Microenvironment: Cellular, Metabolic and Immunologic Interactions

1. Inflammatory components of the thyroid cancer microenvironment - an avenue for identification of novel biomarkers.-  2. Disruption of Cell-Cell Communication in Anaplastic Thyroid Cancer as an Immunotherapeutic Opportunity.- 3. Exosomes in the Healthy and Malignant Bone Marrow Microenvironment.- 4. Structural Biology of the Tumor Microenvironment.- 5. Metabolic interactions between tumor and stromal cells in the Tumor Microenvironment.- 6.  Interacting Genetic Lesions of Melanoma in the Tumor Microenvironment:  Defining a Viable Therapy.- 7. Non-coding RNAs in Papillary Thyroid Cancer: Interaction with cancer associated fibroblasts (CAFs) in the Tumor Microenvironment (TME) and regulators of differentiation and Lymph Node Metastasis.

Dr. Debabrata (Debu) Banerjee, Ph.D., is an Emeritus Professor, Rutgers University having retired as Assistant Dean, School of Graduate Studies and an Associate Professor in the Department of Pharmacology at Rutgers University. He is also an Adjunct Associate Professor at the New York Medical College, positions he has held since 2002. Prior to this, he was an Associate Lab Member at Memorial Sloan-Kettering Cancer Center, New York. Dr. Banerjee obtained a PhD in Biochemistry from Calcutta University and also served as an Adjunct Lecturer for the Department of Biochemistry at Calcutta University. Dr. Banerjee completed his Postdoctoral Fellowship training in the Department of Biology, McGill University, Canada. He has published over 100 peer reviewed research articles in scientific journals. In addition, to his academic appointments, Debu serves as a Member of the Editorial Board for journals Cancers, Cells, PLoS, World Journal of Stem Cells and Current Signal Transduction and Therapy. He is a Reviewer for the journals: Cancer Research, Oncogene, Clinical Cancer Research, Gynecologic Oncology, Journal of Cancer Chemotherapy, British Journal of Cancer, Stem Cells, and Blood. He has extensive experience in preclinical drug development. He has also been awarded 5 patents for his scientific innovations.